Article on the Provision of Elix Discovery™ to KYORIN Pharmaceutical Featured in BioPharmaTrend and AI BRIEF

An article covering the adoption of Elix Discovery™, Elix’s AI drug discovery platform, by KYORIN Pharmaceutical was featured in BioPharmaTrend and AI BRIEF on August 21, 2025.

▼ BioPharmaTrend
KYORIN Pharmaceutical Adopts AI Drug Discovery Platform From Elix

▼ AI BRIEF
Elix Provides AI Drug Discovery Platform to KYORIN Pharmaceutical

Back
Next
View All

Contact Us

Thank you for your interest in Elix. If you have any inquiries about our AI drug discovery platform or conducting joint research, or if you would like to conduct an interview with us, please click the Contact button on the right to get in touch with us.
We will respond as soon as possible.

Contact